Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory study

被引：5

作者：

Kasudhan, Kripa Shanker ^{[1
]}

Patil, Amol N. ^{[1
]}

Jandial, Aditya ^{[2
]}

Khadwal, Alka ^{[2
]}

Prakash, Gaurav ^{[2
]}

Jain, Arihant ^{[2
]}

Bhurani, Dinesh ^{[3
]}

Ahmed, Rayaz ^{[3
]}

Agrawal, Narendra ^{[3
]}

Singh, Reema ^{[3
]}

Sachdeva, Man Updesh Singh ^{[4
]}

Varma, Neelam ^{[4
]}

Das, Reena ^{[4
]}

Verma Attri, Savita ^{[5
]}

Malhotra, Samir ^{[1
]}

Majhail, Navneet S. ^{[6
]}

Malhotra, Pankaj ^{[2
]}

Lad, Deepesh P. ^{[2
]}

机构：

[1] Postgrad Inst Med Educ & Res, Dept Clin Pharmacol, Chandigarh, India

[2] Postgrad Inst Med Educ & Res, Dept Clin Hematol & Med Oncol, Chandigarh, India

[3] Rajiv Gandhi Canc Inst & Res Ctr, Dept Hematooncol, New Delhi, India

[4] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh, India

[5] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh, India

[6] Cleveland Clin, Dept Hematol Oncol, Blood & Marrow Transplant Program, Cleveland, OH USA

来源：

LEUKEMIA & LYMPHOMA | 2022年 / 63卷 / 11期

关键词：

PTCy; pharmacokinetics; CEPM; GVHD; haplo-HCT; VERSUS-HOST-DISEASE; DRUG-METABOLIZING-ENZYMES; POLYMORPHISMS; SURVIVAL; GVHD; TOXICITY; REGIMEN; RELAPSE; PLASMA;

D O I：

10.1080/10428194.2022.2087067

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pharmacokinetics of cyclophosphamide has been explored to optimize conditioning dosing. We hypothesized that post-transplant cyclophosphamide (PTCy) metabolite carboxy-ethyl phosphoramide mustard (CEPM) pharmacokinetics might impact haploidentical transplantation (haplo-HCT) outcomes. CEPM area under the curve (AUC(0-48)) was determined by eleven sampling timepoints on day +3/+4 using LC-MS/MS. The median CEPM AUC(0-48) in a cohort of 30 patients was 14.2 (14) mg center dot hr/L. The incidence of severe chronic graft-versus-host disease (GVHD) (73% vs. 11%, p = 0.02), and GVHD-/relapse-free survival (GRFS) was significantly inferior in the CEPM AUC(0-48) < 14 mg center dot hr/L group (54 days vs. 344 days, p = 0.02). There was, however, no difference in grade III-IV acute GVHD (38% vs. 14%, p = 0.12) and overall survival (295 days vs. not reached, p = 0.2). CEPM AUC(0-48,) is associated with severe chronic GVHD and GRFS post-haplo-HCT in this exploratory study. There is scope for personalizing day + 4 PTCy dose based on day + 3 CEPM AUC(0-8).

引用

页码：2679 / 2685

页数：7

共 50 条

[31] Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease [J].

Harada, Kaito ;

Kanda, Junya ;

Hirayama, Masahiro ;

Wada, Fumiya ;

Uchida, Naoyuki ;

Tanaka, Masatsugu ;

Nakamae, Hirohisa ;

Tokunaga, Masahito ;

Ishiwata, Kazuya ;

Onizuka, Makoto ;

Hasegawa, Yuta ;

Fukuda, Takahiro ;

Eto, Tetsuya ;

Kurita, Naoki ;

Kawakita, Toshiro ;

Jinguji, Atsushi ;

Ishimaru, Fumihiko ;

Atsuta, Yoshiko ;

Nakasone, Hideki .

TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02) :103e1-103e13

[32] Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant [J].

Zhao, Chenchen ;

Bartock, Matthew ;

Jia, Bei ;

Shah, Neal ;

Claxton, David F. ;

Wirk, Baldeep ;

Rakszawski, Kevin L. ;

Nickolich, Myles S. ;

Naik, Seema G. ;

Rybka, Witold B. ;

Ehmann, W. Christopher C. ;

Hohl, Raymond J. ;

Valentin, Jessica ;

Bernas-Peterson, Michelle ;

Gerber, Emily M. ;

Zimmerman, Michele ;

Mierski, Joseph A. ;

Mineishi, Shin ;

Zheng, Hong .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)

[33] Haploidentical hematopoietic stem cells transplantation using post-transplant cyclophosphamide in inborn errors of immunity: Experience in a reference center in Colombia [J].

Medina, Diego ;

Castro, Jhonier Orlando ;

Castro, David Esteban ;

Beltran, Estefania ;

Manzi, Eliana ;

Franco, Alexis Antonio ;

Olaya, Manuela .

BIOMEDICA, 2024, 44 :1-32

[34] Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide [J].

Maeda, Yoshinobu .

JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (01) :1-9

[35] Prophylactic donor lymphocyte infusion after haploidentical hematopoietic cell transplantation and post-transplant cyclophosphamide for treatment of high-risk myeloid neoplasms in children: A retrospective study [J].

Qi, Shan-shan ;

Chen, Zhi ;

Du, Yu ;

Sun, Ming ;

Wang, Zhuo ;

Long, Fei ;

Luo, Linlin ;

Xiong, Hao .

PEDIATRIC BLOOD & CANCER, 2024, 70 (11)

[36] A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study [J].

Chiusolo, Patrizia ;

Bug, Gesine ;

Olivieri, Attilio ;

Brune, Mats ;

Mordini, Nicola ;

Alessandrino, Paolo Emilio ;

Dominietto, Alida ;

Raiola, Anna Maria ;

Di Grazia, Carmen ;

Gualandi, Francesca ;

Van Lint, Maria Teresa ;

Ferrara, Felicetto ;

Finizio, Olimpia ;

Angelucci, Emanuele ;

Bacigalupo, Andrea .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (06) :1243-1249

[37] Pediatric unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and reduced intensity, TBI-free conditioning regimens in salvage transplantations [J].

Wawrzyniak-Dzierzek, Elzbieta ;

Gajek, Kornelia ;

Slezak, Aleksandra ;

Rybka, Blanka ;

Ryczan-Krawczyk, Renata ;

Gorczynska, Ewa ;

Kalwak, Krzysztof ;

Ussowicz, Marek .

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (09) :1223-1228

[38] Post-transplant cyclophosphamide after matched donor hematopoietic stem cell transplantation in children with acute leukemia [J].

Borovkova, Anastasya Svyatoslavovna ;

Paina, Olesya Vladimirovna ;

Semenova, Elena Vladimirovna ;

Bykova, Tatiana Alexandrovna ;

Osipova, Anna Alekseevna ;

Slesarchuk, Olga Alexandrovna ;

Kozhokar, Polina Valerievna ;

Tsvetkova, Lubov Alexandrovna ;

Rakhmanova, Zhemal Zarifovna ;

Kozlov, Andrei Vadimovich ;

Chukhlovin, Alexei Borisovich ;

Kazantsev, Ilya Viktorovich ;

Estrina, Maria Arkadievna ;

Goloshchapov, Oleg Valerievich ;

Bondarenko, Sergei Nikolaevich ;

Moiseev, Ivan Sergeevich ;

Kulagin, Alexander Dmitrievich ;

Zubarovskaya, Ludmila Stepanovna .

CLINICAL TRANSPLANTATION, 2024, 38 (01)

[39] Post-transplant cyclophosphamide versus antithymocyte globulin in allogeneic hematopoietic cell transplantation: a meta-analysis [J].

Gao, Feiqiong ;

Zhang, Jiawei ;

Hu, Jianlai ;

Lin, Liming ;

Xu, Yang .

ANNALS OF HEMATOLOGY, 2021, 100 (02) :529-540

[40] Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide [J].

Oostenbrink, Lisa V. E. ;

Pool, Emma S. ;

Jol-van der Zijde, Cornelia M. ;

Jansen-Hoogendijk, Anja M. ;

Vervat, Carly ;

van Halteren, Astrid G. S. ;

Bredius, Robbert G. M. ;

Smiers, Frans J. W. ;

van Tol, Maarten J. D. ;

Schilham, Marco W. ;

Lankester, Arjan C. ;

Mohseny, Alexander B. .

BONE MARROW TRANSPLANTATION, 2021, 56 (09) :2203-2211

← 1 2 3 4 5 →